MM+M Media Summit 2022 Preview: The telehealth experience

READ MORE

Science: Your Zoom background matters

Klick Applied Sciences research explains why certain types of Zoom backgrounds more effectively fuel creativity than others.

READ MORE

The orphan drug launch, reconsidered

Charlie Gayer, chief commercial officer for BioCryst Pharmaceuticals, talks about how his company, which recently launched an oral medicine into a crowded category, used analytics to rethink the rare-disease drug launch.

LISTEN HERE

Experts assess pharma brand impact of Facebook curtailing health-related targeting

READ MORE

Latest News

Events
MM+M Convene: Media Summit
Join MM+M and a who's-who of health media experts for a candid discussion of the industry's most compelling issues: point of care's post-pandemic pivot, audio's aural appeal, health-friendly evolutions in out-of-home ad tech and much more.
LEARN MORE

Featured Categories

Pharma Next
Vaccines, med-tech thrive in a rattled healthcare ecosystem.
Read the November Issue

From Our Partners

Spectrum Science: Evolving marketing communications following COVID-19
Partner Content
Spectrum Science: Evolving marketing communications following COVID-19

The agency’s biopharma, biotech, health tech and consumer science experts weigh in on how the public’s heightened awareness of science affects stakeholders across the entire healthcare continuum.

The power of purpose
Partner Content
The power of purpose

How Biolumina’s focus on oncology connects the personal with scientific progress.

The emergence of Evolution Health Group
Partner Content
The emergence of Evolution Health Group

Larry Dobrow discusses the evolution of EHG over the past few years with Dr. Leo Francis, COO of EHG, and how his role will focus on creating transformative changes for both employees and clients.

MicroMass and the creative potential of Human Dynamics
Partner Content
MicroMass and the creative potential of Human Dynamics

A look beyond the disease and demographics to understand the human inside.